Amid the COVID-19 crisis, the global market for Physician Dispensed Cosmeceuticals estimated at US$15.4 Billion in the year 2020, is projected to reach a revised size of US$27.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027.Skin Care, one of the segments analyzed in the report, is projected to grow at a 9.9% CAGR to reach US$12.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hair Care segment is readjusted to a revised 8.5% CAGR for the next 7-year period. This segment currently accounts for a 22.8% share of the global Physician Dispensed Cosmeceuticals market.
The U. S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 12% CAGR for the Period of 2020-2027
The Physician Dispensed Cosmeceuticals market in the U. S. is estimated at US$4.2 Billion in the year 2020. The country currently accounts for a 27.03% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$5.9 Billion in the year 2027 trailing a CAGR of 12% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR while Rest of European market (as defined in the study) will reach US$5.9 Billion by the year 2027.
Eye Care Segment Corners a 17.8% Share in 2020
In the global Eye Care segment, USA, Canada, Japan, China and Europe will drive the 7.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.1 Billion in the year 2020 will reach a projected size of US$3.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.9 Billion by the year 2027, while Latin America will expand at a 9.6% CAGR through the analysis period. The publisher brings years of research experience to this 16th edition of our report. The 311-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others
- Allergan Plc
- Athena Cosmetics Inc.
- Biopelle Inc.
- Clinique Laboratories LLC
- Jan Marini Skin Research Inc.
- Neutrogena Corp.
- Obagi Medical Products Inc.
- SkinCeuticals
- SkinMedica Inc.
- Solta Medical Inc.
- Stiefel Laboratories Inc.
- ZO® Skin Health Inc.
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Physician Dispensed Cosmeceuticals: Delivering Health and Beauty
Recent Market Activity
Asia-Pacific to Witness Strong Growth in the Future
Physician Dispensed Skin Care Products Gain Traction
Competitive Landscape
Global Competitor Market Shares
Physician Dispensed Cosmeceuticals Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Allergan Plc (Ireland)
SkinMedica, Inc. (USA)
Athena Cosmetics, Inc. (USA)
Biopelle, Inc. (USA)
Clinique Laboratories, LLC (USA)
Innovative Skincare® (iS Clinical) (USA)
Jan Marini Skin Research, Inc. (USA)
La Roche-Posay Laboratoire Pharmaceutique (France)
Neutrogena Corp. (USA)
Obagi Medical Products, Inc. (USA)
Pacific Bioscience Laboratories, Inc. (USA)
SkinCeuticals (USA)
Solta Medical, Inc. (USA)
Stiefel Laboratories, Inc. (USA)
ZO® Skin Health, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Mid-Life Crisis - A Key Growth Driver
Cosmeceutical Consumers: A Highly Informed, Aesthetically-Conscious Group
Natural Ingredients Gain Attention
What’s Next in Ingredients?
Women Account for Highest Spends on Skin Care
Customized Solutions for Uninsured Patients to go a Long Way
Physician Dispensed Cosmeceuticals - A Potential Path to Invasive Procedures
Post Procedure Topical Products in Demand
Physician Dispensing Outsmarts Conventional Retail Brands
Manufacturers Widen Customer Base
Innovative Ingredients Gain Focus
Anti-Aging Products: The Largest Segment in Skin Care Cosmeceuticals
Major Anti-Aging Ingredients of Cosmeceuticals
Major Anti-Aging Ingredients of Cosmeceuticals
Popular Cosmeceutical Contents
Stem Cell Technology: The New Frontier
Skin Brightening and Lightening Products - A High Growth Market
Companies Focus on Complementary Products
Possible Ban on Hydroquinone Stimulates Search for Other Pigment Control Products
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Physician Dispensed Cosmeceuticals Market Share (in %) by Company: 2020 & 2025
Market Analytics
CANADA
JAPAN
CHINA
EUROPE
Market Facts & Figures
European Physician Dispensed Cosmeceuticals Market: Competitor Market Share Scenario (in %) for 2020 & 2025
Market Analytics
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
IV. COMPETITION
Total Companies Profiled: 68
LOADING...
